A Multicenter VESIcare® Efficacy and Safety Study for the Treatment of Urgency Associated With Overactive Bladder (OAB)

NCT00454896 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

739

Enrollment

INDUSTRY

Sponsor class

Conditions

Urinary Bladder, Overactive

Interventions

DRUG: VESIcare®
DRUG: placebo

Sponsor

Astellas Pharma Inc